Alaunos Therapeutics Reports First Quarter 2023 Financial Results (GlobeNewswire) - May 10, 2023 - "Recent Developments and Upcoming Milestones: TCR-T Library Phase 1/2 trial actively enrolling patients:...Alaunos currently expects to provide an interim data update on multiple new patients in the third quarter of this year as the Company advances the program towards Phase 2 readiness with a recommended Phase 2 dose anticipated by year end 2023."
P1/2 data • Trial status • Oncology • Solid Tumor
|